[Status quo of experimental and clinical studies in retarding kidney damage of chronic nephropathy by ligustrazine]

Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 May;17(5):314-5.
[Article in Chinese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Calcium Channel Blockers / pharmacology
  • Free Radical Scavengers / pharmacology
  • Glomerulosclerosis, Focal Segmental / drug therapy
  • Humans
  • Kidney Failure, Chronic / drug therapy
  • Platelet Aggregation Inhibitors / pharmacology
  • Pyrazines / adverse effects
  • Pyrazines / pharmacology*
  • Pyrazines / therapeutic use

Substances

  • Calcium Channel Blockers
  • Free Radical Scavengers
  • Platelet Aggregation Inhibitors
  • Pyrazines
  • tetramethylpyrazine